All News Champions Oncology, Inc.

Equities

CSBR

US15870P3073

Delayed Nasdaq Other stock markets 01:18:40 2024-05-21 pm EDT			5-day change	1st Jan Change
4.715 ^USD	-0.95%		+1.62%	-16.10%

Mar. 15	Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	CI
Mar. 13	Craig-Hallum Downgrades Champions Oncology to Hold From Buy	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	Mar. 15	CI
Craig-Hallum Downgrades Champions Oncology to Hold From Buy	Mar. 13	MT
Champions Oncology, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024	Mar. 12	CI
Transcript : Champions Oncology, Inc., Q3 2024 Earnings Call, Mar 12, 2024	Mar. 12
Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation	Mar. 08	AQ
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	Dec. 13	CI
Craig Hallum Trims Champions Oncology Price target to $9 From $10, Maintains Buy Rating	Dec. 13	MT
Transcript : Champions Oncology, Inc., Q2 2024 Earnings Call, Dec 12, 2023	Dec. 12
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2023	Dec. 12	CI
MORNING BID AMERICAS-Disinflation station	Dec. 12	RE
North American Morning Briefing : Traders Eye -2-	Dec. 12	DJ
Champions Oncology, Inc.	Nov. 02	AQ
Champions Oncology Announces the Addition of Brady Davis as President	23-10-18	AQ
Champions Oncology, Inc. Appoints Brady Davis as President	23-10-17	CI
Roth MKM Adjusts Price Target on Champions Oncology to $7.50 From $9, Maintains Buy Rating	23-09-22	MT
Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023.	23-09-13	CI
Transcript : Champions Oncology, Inc., Q1 2024 Earnings Call, Sep 13, 2023	23-09-13
Champions Oncology : Reports Quarterly Revenue of $12.6 Million - Form 8-K	23-09-13	PU
Champions Oncology, Inc. Reports Earnings Results for the First Quarter Ended July 31, 2023	23-09-13	CI
Champions Oncology Announces a Multi-Year Agreement and Strategic Collaboration with BioVolume to Transform Reproducibility in Preclinical Oncology Efficacy Studies	23-08-02	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Champions Oncology, Inc.

Equities

CSBR

US15870P3073

All News

Filters